FBInvestor
Stocks / Armata Pharmaceuticals Inc
Institutional Ownership

Armata Pharmaceuticals Inc

CUSIP 04216R102COMARMPQ1 2026

13D / 13G Filings
23
Schedule 13D/13G on record
Beneficial Filers
1
Distinct reporting persons
Largest Stake
100.0%
Max % of class reported
Institutional Holders
42
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

23 filings · latest Jan 26, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Jan 26, 2026Innoviva, Inc.13D/A83.1%SEC
2Aug 12, 2025Innoviva, Inc.13D/A83.3%SEC
3Mar 12, 2025Innoviva, Inc.13D/A85.2%SEC
4Nov 14, 2024Innoviva, Inc.13D/A85.2%64.18MSEC
5Mar 4, 2024Innoviva, Inc.13D/A85.3%64.18MSEC
6Jul 11, 2023Innoviva, Inc.13D/A85.3%64.18MSEC
7Jan 10, 2023Innoviva, Inc.13D/A85.3%64.18MSEC
8Jul 11, 2022Innoviva, Inc.13D/A100.0%SEC
9May 24, 2022Innoviva, Inc.13D/A74.9%57.35MSEC
10Apr 1, 2022Innoviva, Inc.13D/A80.1%44.44MSEC

13 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Armata Pharmaceuticals Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →